Zulma Cucunubá

Biographic Data

ID7502334
NAMEZulma Cucunubá
GIVEN NAMESZulma
FAMILY NAMECucunubá
SIGNATURECUCUNUBÁ Z
AFFILIATIONSImperial College London
VERIFIEDNo
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2017
LATEST PUBLICATION YEAR2021
H-INDEX0

  • Understanding How Socioeconomic Inequalities Drive Inequalities in Covid-19 Infections

    Open AccessRachid Laajaj, Duncan Webb et al.ARTICLESSRN Electronic Journal2021

  • Estimating the effects of non-pharmaceutical interventions on Covid-19 in Europe

    Open AccessSeymour Flaxman, Seth Flaxman et al.ARTICLENature2020

  • The impact of Covid-19 and strategies for mitigation and suppression in low- and middle-income countries

    Open AccessPatrick G T Walker, Charles Whittaker et al.ARTICLEScience2020

    Global prospects for COVID-19 control Lower-income countries have recognized the potential impact of coronavirus disease 2019 (COVID-19) from observing ongoing epidemics. Many have intervened quickly and early with measures to slow viral transmission, which may partly explain the low rates observed so far in these countries. Walker et al. calibrated a global model with country-specific data (see the Perspective by Metcalf et al. ). Despite the po…

  • Estimates of the severity of coronavirus disease 2019

    Open AccessRobert Verity, Lucy Okell et al.ARTICLEThe Lancet Infectious Diseases2020

    BACKGROUND: In the face of rapidly changing data, a range of case fatality ratio estimates for coronavirus disease 2019 (COVID-19) have been produced that differ substantially in magnitude. We aimed to provide robust estimates, accounting for censoring and ascertainment biases. METHODS: We collected individual-case data for patients who died from COVID-19 in Hubei, mainland China (reported by national and provincial health commissions to Feb 8, 2…

  • Increasing access to comprehensive care for Chagas disease

    Open AccessAndrea Marchiol, C Forsyth et al.ARTICLERevista Panamericana de Salud…2017

    Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Colombia, 437 000 people are infected with T. cruzi, of whom 131 000 suffer from cardiomyopathy. Colombia's annual costs for treating patients with advanced CD reach US$ 175 016 000. Although timely etiological treatment …